Paper20043028
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
Jackson AL and 1 other. Nat Rev Drug Discov, 2010. Cited by 859 papers, by iCite.
Cite this record
ConductScience Library. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Papers, record 20043028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20043028
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Silencing | Major topic |
| Gene Targeting | Major topic |
| RNA, Small Interfering | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Genetic Therapy | |
| Humans | |
| MicroRNAs |
Source PubMed
References114
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14668052 | Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. | J Drug Target | 2003 | https://conductscience.org/library/papers/14668052 | PubMed |
| 2 | 17652171 | Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17652171 | PubMed |
| 3 | 15735639 | Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. | Nature | 2005 | https://conductscience.org/library/papers/15735639 | PubMed |
| 4 | 16091630 | siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/16091630 | PubMed |
| 5 | 15806104 | Combinatorial microRNA target predictions. | Nat Genet | 2005 | https://conductscience.org/library/papers/15806104 | PubMed |
| 6 | 12554881 | Sequence requirements for micro RNA processing and function in human cells. | RNA | 2003 | https://conductscience.org/library/papers/12554881 | PubMed |
| 7 | 15813981 | Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. | J Inflamm (Lond) | 2004 | https://conductscience.org/library/papers/15813981 | PubMed |
| 8 | 18155315 | Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. | Adv Drug Deliv Rev | 2008 | https://conductscience.org/library/papers/18155315 | PubMed |
| 9 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 10 | 15685193 | Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. | Nature | 2005 | https://conductscience.org/library/papers/15685193 | PubMed |
| 11 | 19239886 | Origins and Mechanisms of miRNAs and siRNAs. | Cell | 2009 | https://conductscience.org/library/papers/19239886 | PubMed |
| 12 | 11157775 | RNA interference is mediated by 21- and 22-nucleotide RNAs. | Genes Dev | 2001 | https://conductscience.org/library/papers/11157775 | PubMed |
| 13 | 17579574 | 2'-O-methyl-modified RNAs act as TLR7 antagonists. | Mol Ther | 2007 | https://conductscience.org/library/papers/17579574 | PubMed |
| 14 | 10749213 | An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. | Nature | 2000 | https://conductscience.org/library/papers/10749213 | PubMed |
| 15 | 15695330 | RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15695330 | PubMed |
| 16 | 12198168 | MicroRNA maturation: stepwise processing and subcellular localization. | EMBO J | 2002 | https://conductscience.org/library/papers/12198168 | PubMed |
| 17 | 12672692 | The microRNAs of Caenorhabditis elegans. | Genes Dev | 2003 | https://conductscience.org/library/papers/12672692 | PubMed |
| 18 | 12789138 | Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. | Mol Vis | 2003 | https://conductscience.org/library/papers/12789138 | PubMed |
| 19 | 16308212 | Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. | J Drug Target | 2005 | https://conductscience.org/library/papers/16308212 | PubMed |
| 20 | 10617568 | Targeted mRNA degradation by double-stranded RNA in vitro. | Genes Dev | 1999 | https://conductscience.org/library/papers/10617568 | PubMed |
Cited by551
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 859 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984764 | Inducible and reversible in vivo protein degradation reveals T cell-intrinsic regulatory function of SHP-1. | Front Immunol | 2026 | https://conductscience.org/library/papers/42984764 | PubMed |
| 42964787 | Controlling the controls: On the importance of validated negative control ASOs. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42964787 | PubMed |
| 42911498 | Cas13d-Mediated Knockdown of Long Noncoding RNAs. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42911498 | PubMed |
| 42886793 | Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition. | Sci Adv | 2026 | https://conductscience.org/library/papers/42886793 | PubMed |
| 42846378 | Host-directed therapeutics against antimicrobial-resistant bacterial infections: emerging roles of multi-omics and systems biology. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42846378 | PubMed |
| 42729488 | From RNA design to delivery: Computational strategies for functional RNA therapeutics. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42729488 | PubMed |
| 42688902 | Generation of spCAS9 expressing human mesenchymal stem cell line to study gene function during osteoblast differentiation. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42688902 | PubMed |
| 42650879 | p21 (CDKN1A) Is the Major Driver of Sulforaphane-Mediated Reduction in SAMHD1 T592 Phosphorylation in Macrophages. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650879 | PubMed |
| 42608568 | LncRNA SNHG14 drives alveolar inflammation in bronchopulmonary dysplasia via DNMT3a-mediated epigenetic silencing of miR-214-3p. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42608568 | PubMed |
| 42597608 | Design and development of lipid nanoparticle formulations for brain gene therapy. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42597608 | PubMed |
| 42439627 | CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells. | Cells | 2026 | https://conductscience.org/library/papers/42439627 | PubMed |
| 42382979 | Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics. | Antib Ther | 2026 | https://conductscience.org/library/papers/42382979 | PubMed |
| 42367245 | Understanding the biological limits of hybridization-dependent siRNA off-target interactions. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42367245 | PubMed |
| 42360639 | The Diagnostic and Therapeutic Value of Micro-RNA in Parkinson's Disease. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42360639 | PubMed |
| 42282505 | Unveiling the Silent Regulators: Noncoding RNAs in Parasitic Disease Diagnosis and Therapy. | J Parasitol Res | 2026 | https://conductscience.org/library/papers/42282505 | PubMed |
| 42200443 | Hsp70 is phosphorylated in a conserved response to DNA damage and contributes to cell cycle control. | Elife | 2026 | https://conductscience.org/library/papers/42200443 | PubMed |
| 42198287 | Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198287 | PubMed |
| 42040413 | Molecular Dynamics Simulation-Assisted siRNA Design for Dual-Ubiquitinated SKP2 Silencing via Ago2 Anchoring in Breast Cancer. | ACS Omega | 2026 | https://conductscience.org/library/papers/42040413 | PubMed |
| 41984920 | Higher order synthetic lethals are keys to minimize cancer treatment effects on non-tumor cells. | PLoS One | 2026 | https://conductscience.org/library/papers/41984920 | PubMed |
| 41959736 | Molecular mastery: Harnessing DNA technology for disease prevention. | Genes Dis | 2026 | https://conductscience.org/library/papers/41959736 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20043028
GET https://conductscience.org/api/papers/v1/20043028/references?page=2